ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device ...

Recently published results from the Cardiovascular and Interventional Radiological Society of Europe (“CIRSE”) vascular closure device registry further validated the safety and efficacy of medical ...

Kensey Nash originally developed Angio-Seal, and St. Jude bought the marketing and manufacturing rights for the device from Tyco International in early 1999. "Angio-Seal will now be marketed by one of ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Results from a Cordis analysis presented at the 14 th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) congress in Madrid indicates ...

ST. PAUL, Minn., March 17 (UPI) -- St. Jude Medical said Friday it has launched its newly approved vascular closure device to seal arteries in surgery. The device maker said the Angio-Seal VIP -- ...

SAN FRANCISCO (MarketWatch) -- Kensey Nash Corp. after Tuesday's closing bell said that it has executed a new supply contract with St. Jude Medical Inc. for the Angio-Seal vascular closure device ...

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...

Procedures involving use of a collagen plug-based vascular closure device rarely led to the onset of critical limb ischemia, according to results of a new study. Researchers retrospectively ...

The Mynx grip vascular closure device. The study found the Mynx was associated with “a significantly greater risk of vascular complication” compared to alternative vascular-closure devices like the ...